Unichem Laboratories lost 3.55% to Rs 188.65 at 10:24 IST on BSE after net profit declined 16.34% to Rs 30.19 crore on 9.57% growth in total income from operations to Rs 291 crore in Q1 June 2014 over Q1 June 2013.
The Q1 result was announced on Saturday, 12 July 2014.
Meanwhile, the S&P BSE Sensex was down 15.85 points or 0.06% at 25,008.50.
On BSE, so far 6,372 shares were traded in the counter as against average daily volume of 25,318 shares in the past one quarter.
The stock hit a high of Rs 196 and a low of Rs 187 so far during the day. The stock had hit a 52-week low of Rs 138 on 7 August 2013. The stock had hit a 52-week high of Rs 241.45 on 4 July 2014.
The stock had underperformed the market over the past one month till 11 July 2014, sliding 5.21% compared with Sensex's 1.76% fall. The scrip had also underperformed the market in past one quarter, declining 12.7% as against Sensex's 10.59% rise.
The small-cap pharmaceutical company has equity capital of Rs 18.13 crore. Face value per share is Rs 2.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
Powered by Capital Market - Live News
